Literature DB >> 11115331

Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis.

N B Farber1, E H Rubin, J W Newcomer, D A Kinscherf, J P Miller, J C Morris, J W Olney, D W McKeel.   

Abstract

BACKGROUND: Psychosis is common in patients with Alzheimer disease. While the relationship between psychosis and clinical variables has been examined frequently, few studies have examined the relationship between psychosis and the 2 major neuropathological hallmarks of Alzheimer disease: neurofibrillary tangles and senile plaques. We characterized the occurrence of psychosis in relation to dementia severity and determined if subjects with Alzheimer disease and psychosis had a greater neurofibrillary tangle or senile plaque burden than subjects with Alzheimer disease and no psychosis.
METHODS: One hundred nine subjects with Alzheimer disease were followed longitudinally with semistructured assessments in order to assign a Clinical Dementia Rating and determine whether psychosis was present. After the subjects died, their brains were obtained for histological examination. Analysis of variance was used to compare the densities of neurofibrillary tangles, total senile plaques, and cored senile plaques in subjects with psychosis vs subjects without psychosis, in several neocortical regions, the hippocampus, and the entorhinal cortex.
RESULTS: Psychosis occurred commonly in Alzheimer disease, affecting 63% of subjects. The frequency of psychosis increased with increasing dementia severity. More importantly, we found that subjects with psychosis had a 2.3-fold (95% confidence interval, 1.2-3.9) greater density of neocortical neurofibrillary tangles than did subjects without psychosis. The increase was independent of dementia severity. No similar relationship with psychosis was seen for total senile plaques or cored senile plaques.
CONCLUSIONS: The increase in psychosis frequency that occurs with the progression of dementia severity and the independent association between psychosis and neurofibrillary tangle density suggest the possibility that some common underlying process or processes specific to Alzheimer disease may regulate both phenomena. Arch Gen Psychiatry. 2000;57:1165-1173.

Entities:  

Mesh:

Year:  2000        PMID: 11115331     DOI: 10.1001/archpsyc.57.12.1165

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  44 in total

1.  Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.

Authors:  Corinne E Fischer; Winnie Qian; Tom A Schweizer; Colleen P Millikin; Zahinoor Ismail; Eric E Smith; Lisa M Lix; Paul Shelton; David G Munoz
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

2.  Neurobiology of delusions, memory, and insight in Alzheimer disease.

Authors:  David L Sultzer; Lorraine P Leskin; Rebecca J Melrose; Dylan G Harwood; Theresa A Narvaez; Timothy K Ando; Mark A Mandelkern
Journal:  Am J Geriatr Psychiatry       Date:  2013-09-08       Impact factor: 4.105

3.  No association of psychosis in Alzheimer disease with neurodegenerative pathway genes.

Authors:  Mary Ann A DeMichele-Sweet; Lambertus Klei; Bernie Devlin; Robert E Ferrell; Elise A Weamer; James E Emanuel; Oscar L Lopez; Robert A Sweet
Journal:  Neurobiol Aging       Date:  2010-11-18       Impact factor: 4.673

4.  Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease.

Authors:  Julia Kim; Corinne E Fischer; Tom A Schweizer; David G Munoz
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

5.  β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis.

Authors:  Patrick S Murray; Caitlin M Kirkwood; Megan C Gray; Milos D Ikonomovic; William R Paljug; Eric E Abrahamson; Ruth A Henteleff; Ronald L Hamilton; Julia K Kofler; William E Klunk; Oscar L Lopez; Peter Penzes; Robert A Sweet
Journal:  Neurobiol Aging       Date:  2012-03-17       Impact factor: 4.673

Review 6.  Organic psychosis: Insight into the biology of psychosis.

Authors:  N T Lautenschlager; H Förstl
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

Review 7.  Neuropsychiatric Symptoms in Mild Cognitive Impairment.

Authors:  Damien Gallagher; Corinne E Fischer; Andrea Iaboni
Journal:  Can J Psychiatry       Date:  2017-03       Impact factor: 4.356

Review 8.  Determinants of behavioral and psychological symptoms of dementia: A scoping review of the evidence.

Authors:  Ann Kolanowski; Marie Boltz; Elizabeth Galik; Laura N Gitlin; Helen C Kales; Barbara Resnick; Kimberly S Van Haitsma; Amy Knehans; Jane E Sutterlin; Justine S Sefcik; Wen Liu; Darina V Petrovsky; Lauren Massimo; Andrea Gilmore-Bykovskyi; Margaret MacAndrew; Glenna Brewster; Vycki Nalls; Ying-Ling Jao; Naomi Duffort; Danny Scerpella
Journal:  Nurs Outlook       Date:  2017-06-16       Impact factor: 3.250

9.  TAR DNA-binding protein 43 pathology in Alzheimer's disease with psychosis.

Authors:  Anil Varma V Vatsavayi; Julia Kofler; Mary Ann A Demichele-Sweet; Patrick S Murray; Oscar L Lopez; Robert A Sweet
Journal:  Int Psychogeriatr       Date:  2014-03-04       Impact factor: 3.878

Review 10.  Leptin: a novel therapeutic strategy for Alzheimer's disease.

Authors:  Nikolaos Tezapsidis; Jane M Johnston; Mark A Smith; J Wesson Ashford; Gemma Casadesus; Nikolaos K Robakis; Benjamin Wolozin; George Perry; Xiongwei Zhu; Steven J Greco; Sraboni Sarkar
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.